A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-27

Study Completion Date

2028-12-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a population of more than 150 million, China has the largest number of CKD patients all over the world. People with CKD would not only progress to uremia and need renal replace treatment, it also significantly increases risk of cardiovascular disease than non-CKD population. It has created a heavy burden on people's health and national economy. There is an urgent need to establish an effective system for CKD prevention and control in China. Evidences from large sample cohort and real world based research are still rare. This study will provide good experience for reducing the occurrence and development of CKD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chinese Cohort Study of Chronic Kidney Disease

NCT03041987

Renal Insufficiency, Chronic

ACTIVE_NOT_RECRUITING

Chronic Kidney Disease Registry Platform Study

NCT06117852

Chronic Kidney Diseases

RECRUITING

Multi-omics Analysis of Chronic Kidney Disease

NCT05543291

Potential Mechanisms Underlying the Microbiota-Gut-Kidney Axis in CKD

UNKNOWN

China Collaborative Study on Epidemiology of Acute Kidney Injury

NCT03054142

Acute Kidney Injury

RECRUITING

Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease

NCT03246191

Chronic Kidney Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed as an investigator-initiated, multi-center, prospective and observational real world study based on mainland Chinese population. The investigators aimed to investigate the occurrence, development, treatment, prognosis state and related risk factors of CKD in China.

This study based on the standardized data network, which provides efficient data collection, integration and analysis for researchers and clinicians in multi-centers.

The sample size of this study was estimated by statisticians, epidemiologists and clinicians. Real-world studies adopted an open standard for inclusion and exclusion, larger sample size could cover a wider group of patients and take the possibility of loss of follow-up into account. Subgroup analysis can be performed in a heterogeneous population and expand the significance of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition;
* Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD;
* Healthy population.
* Signed the informed consent voluntarily.

Exclusion Criteria

。Patients identified to be unsuitable for enrollment by the study physician.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

XueQing Yu

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xueqing Yu, MD

Role: STUDY_CHAIR

Guangdong Provincial People's Hospital

Zhiming Ye, MD

Role: STUDY_DIRECTOR

Guangdong Provincial People's Hospital

Feng Wen, MD

Role: PRINCIPAL_INVESTIGATOR

Guangdong Provincial People's Hospital

Ting Lin, MD

Role: PRINCIPAL_INVESTIGATOR

Guangdong Provincial People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.